ZimVie Announces FDA Clearance And U.S. Launch Of GenTek Restorative Components

7/23/24 8:13:53 AM ET

Medical/Dental Instruments

Health Care

Get the next $ZIMV alert in real time by email

ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced the U.S. launch of its GenTek® Genuine Restorative Components product portfolio. The launch expands ZimVie's portfolio of end-to-end prosthetic offerings and follows the recent receipt of FDA 510(k) clearance. ZimVie first launched the GenTek portfolio in Europe in 2019 and has seen tremendous success in that market to date.

Get the next $ZIMV alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ZIMV

Date	Price Target	Rating	Analyst
5/16/2024	$20.00	Hold → Buy	Needham
11/16/2023		Hold	Needham
12/21/2022	$9.00	Underweight	Barclays
6/17/2022	$20.00	Neutral	JP Morgan
3/18/2022		Neutral	Guggenheim

More analyst ratings

ZimVie Reports Third Quarter 2024 Financial Results
Third Party Net Sales from Continuing Operations of $103.2 millionNet Loss from Continuing Operations of $(3.0) million; Net Loss margin of (3.0%) Adjusted EBITDA[1] from Continuing Operations of $13.1 million; Adjusted EBITDA[1] margin of 12.7%GAAP diluted EPS from Continuing Operations of $(0.11) and adjusted diluted EPS of $0.12 PALM BEACH GARDENS, Fla., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended September 30, 2024. Management will host a corresponding conference call today, October 30, 2024, at 4:30 p.m. Eastern Time. "In the third quarter we saw an improvement
10/30/24 4:05:00 PM ET
$ZIMV
Medical/Dental Instruments
Health Care
ZimVie to Present at the UBS Global Healthcare Conference
PALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available on ZimVie's investor website at investor.zimvie.com. About ZimVieZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and r
10/29/24 4:05:00 PM ET
$ZIMV
Medical/Dental Instruments
Health Care
ZimVie to Report Third Quarter Financial Results on October 30, 2024
PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at investor.zimvie.com About ZimVie ZimVie is a global life sciences leader in the dental market that develops, manu
10/16/24 4:05:00 PM ET
$ZIMV
Medical/Dental Instruments
Health Care

$ZIMV
Financials

Live finance-specific insights

ZimVie Reports Third Quarter 2024 Financial Results
Third Party Net Sales from Continuing Operations of $103.2 millionNet Loss from Continuing Operations of $(3.0) million; Net Loss margin of (3.0%) Adjusted EBITDA[1] from Continuing Operations of $13.1 million; Adjusted EBITDA[1] margin of 12.7%GAAP diluted EPS from Continuing Operations of $(0.11) and adjusted diluted EPS of $0.12 PALM BEACH GARDENS, Fla., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended September 30, 2024. Management will host a corresponding conference call today, October 30, 2024, at 4:30 p.m. Eastern Time. "In the third quarter we saw an improvement
10/30/24 4:05:00 PM ET
$ZIMV
Medical/Dental Instruments
Health Care
ZimVie to Report Third Quarter Financial Results on October 30, 2024
PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at investor.zimvie.com About ZimVie ZimVie is a global life sciences leader in the dental market that develops, manu
10/16/24 4:05:00 PM ET
$ZIMV
Medical/Dental Instruments
Health Care
ZimVie Reports Second Quarter 2024 Financial Results
Third Party Net Sales from Continuing Operations of $116.8 millionNet Loss from Continuing Operations of $(9.6) million; Net Loss margin of (8.2%) Adjusted EBITDA[1] from Continuing Operations of $16.1 million; Adjusted EBITDA[1] margin of 13.8%Reduced debt to $235.1 million, ended quarter with cash balance from Continuing Operations of $78.6 million PALM BEACH GARDENS, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended June 30, 2024. Management will host a corresponding conference call today, August 1, 2024, at 4:30 p.m. Eastern Time. "We continued to execute in the
8/1/24 4:05:00 PM ET
$ZIMV
Medical/Dental Instruments
Health Care

ZimVie Announces FDA Clearance And U.S. Launch Of GenTek Restorative Components

Chat with this insight

Recent Analyst Ratings for
$ZIMV

$ZIMV
SEC Filings

SEC Form 10-Q filed by ZimVie Inc.

ZimVie Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

SEC Form 10-Q filed by ZimVie Inc.

$ZIMV
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Officer Heppenstall Richard covered exercise/tax liability with 1,058 shares, decreasing direct ownership by 1% to 90,687 units (SEC Form 4)

SEC Form 4 filed by Director Kuntz Richard

SEC Form 4 filed by Director King David P

$ZIMV
Press Releases

Fastest customizable press release news feed in the world

$ZIMV
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

ZimVie Reports Third Quarter 2024 Financial Results

ZimVie to Present at the UBS Global Healthcare Conference

ZimVie to Report Third Quarter Financial Results on October 30, 2024

ZimVie upgraded by Needham with a new price target

Needham initiated coverage on ZimVie

Barclays initiated coverage on ZimVie with a new price target

$ZIMV
Financials

Live finance-specific insights

ZimVie Reports Third Quarter 2024 Financial Results

ZimVie to Report Third Quarter Financial Results on October 30, 2024

ZimVie Reports Second Quarter 2024 Financial Results

$ZIMV
Market Insights

Live Market Insights

ZimVie shares are trading higher after the company announced FDA clearance and U.S. launch of GenTek Restorative Components.